Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-18
2008-03-18
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S148000
Reexamination Certificate
active
11048992
ABSTRACT:
The invention relates to compounds having pharmacological activity towards the 5-HT7 receptor, and more particularly to some some tetrahydroisoquinoline substituted sulfonamide compounds, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use for the treatment and or prophylaxis of a disease in which 5-HT is involved, such as CNS disorders.
REFERENCES:
patent: 0 021 580 (1983-12-01), None
patent: 0 076 072 (1987-05-01), None
patent: WO 97/29097 (1997-08-01), None
patent: WO 97/48681 (1997-12-01), None
patent: WO 97/49695 (1997-12-01), None
patent: WO 99/24022 (1999-05-01), None
patent: WO 00/00472 (2000-01-01), None
patent: WO 03/048118 (2003-06-01), None
Terron, J. A., IDrugs, vol. 1(3), pp. 302-301, 1998.
Lovenberg et al., Neuron, vol. 11, pp. 449-458, 1993.
Terron, J. A., Br. J. Pharmacol., vol. 121, pp. 563-571, 1997.
Schoefter et al., Br. J. Pharmacol., vol. 117, pp. 993-994, 1996.
Terron, J. A., Eur. J. Pharmacol., vol. 439, pp. 1-11, 2002.
De Ponti et al., Drugs, vol. 61, pp. 317-332, 2001.
Read et al., Br. J. Pharmacol., vol. 140, pp. 53-60, Jul. 29, 2003.
Wesolowska, A., Polish J. Pharmacol., vol. 54, pp. 327-341, 2002.
Whaley, Organic Reactions, vol. 6 (chapter 3), pp. 151-190, 1951.
Munson et al., Anal. Biochem., vol. 107, pp. 220-239, 1980.
Vermeulen et al., J. Med. Chem., vol. 47, pp. 5451-5466, Sep. 23, 2004.
European Patent Office, European Search Report for EP 04380279.2, issued May 23, 2005.
Alonso Luz Romero
Buschmann Helmut H.
Dordal Zueras Alberto
Jover Antoni Torrens
Mas Prio Jose
Davis Zinna N.
Laboratorios Del Dr. Esteve, S.A.
Morgan & Finnegan L.L.P.
LandOfFree
5-HT7 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-HT7 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-HT7 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3951933